Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up

Leukemia, Published online: 28 February 2024; doi:10.1038/s41375-024-02192-zPhase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up
Source: Leukemia - Category: Hematology Authors: Source Type: research
More News: Hematology | Leukemia | Myeloma